Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Genetically engineered immune cells show promise for fighting relapsed blood cancer

Science Daily - 3 Dec 2018 23:27
Researchers are presenting preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.
Full Article at Science Daily

More Science News
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard